AAAAAA

   
Results: 1-3 |
Results: 3

Authors: KEHNE JH KANE JM CHANEY SF HURST G MCCLOSKEY TC PETTY MA SENYAH Y WOLF HH ZOBRIST R WHITE HS
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF MDL-27,192 AS A POTENTIAL BROAD-SPECTRUM ANTICONVULSANT AGENT WITH NEUROPROTECTIVE PROPERTIES, Epilepsy research, 27(1), 1997, pp. 41-54

Authors: KEHNE JH BARON BM CARR AA CHANEY SF ELANDS J FELDMAN DJ FRANK RA VANGIERSBERGEN PLM MCCLOSKEY TC JOHNSON MP MCCARTY DR POIROT M SENYAH Y SIEGEL BW WIDMAIER C
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 968-981

Authors: THOMAS CE BERNARDELLI P BOWEN SM CHANEY SF FRIEDRICH D JANOWICK DA JONES BK KEELEY FJ KEHNE JH KETTELER B OHLWEILER DF PAQUETTE LA ROBKE DJ FEVIG TL
Citation: Ce. Thomas et al., CYCLIC NITRONE FREE-RADICAL TRAPS - ISOLATION, IDENTIFICATION, AND SYNTHESIS OF 3,3-DIMETHYL-3,4-DIHYDROISOQUINOLIN-4-OL N-OXIDE, A METABOLITE WITH REDUCED SIDE-EFFECTS, Journal of medicinal chemistry, 39(25), 1996, pp. 4997-5004
Risultati: 1-3 |